|
|
|
|
| LEADER |
03781nmm a2200985 u 4500 |
| 001 |
EB002165874 |
| 003 |
EBX01000000000000001303653 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
230607 ||| eng |
| 020 |
|
|
|a 9780841220522
|
| 050 |
|
4 |
|a RS431.C23
|
| 100 |
1 |
|
|a Marchessault, R. H.
|e [editor]
|
| 245 |
0 |
0 |
|a Polysaccharides for drug delivery and pharmaceutical applications
|c Robert H. Marchessault, editor ; François Ravenelle, editor ; Xiao Xia Zhu, editor ; sponsored by the ACS Division of Cellulose and Renewable Materials
|
| 260 |
|
|
|a Washington, DC
|b American Chemical Society
|c 2006, 2006
|
| 300 |
|
|
|a 388 pages
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references and index
|
| 653 |
|
|
|a Carbohydrates
|
| 653 |
|
|
|a Delayed-Action Preparations
|
| 653 |
|
|
|a Excipients
|
| 653 |
|
|
|a MEDICAL / Pharmacology / bisacsh
|
| 653 |
|
|
|a Drug delivery systems
|
| 653 |
|
|
|a Polysaccharides
|
| 653 |
|
|
|a Proteins / therapeutic use
|
| 653 |
|
|
|a Chitosan / Effect of temperature on
|
| 653 |
|
|
|a Chitosan / Utilization
|
| 653 |
|
|
|a Separation / Technique
|
| 653 |
|
|
|a Cellulose nanocrystals / Magnetic properties
|
| 653 |
|
|
|a Microencapsulation
|
| 653 |
|
|
|a Cellulose / Application
|
| 653 |
|
|
|a Viscoelastic materials / Formation
|
| 653 |
|
|
|a Cellulose
|
| 653 |
|
|
|a Magnetic Phenomena
|
| 653 |
|
|
|a Polymeric drug delivery systems
|
| 653 |
|
|
|a Temperature
|
| 653 |
|
|
|a Peptides / Therapeutic use
|
| 653 |
|
|
|a Solid dosage forms / Formation
|
| 653 |
|
|
|a Cellulose / analogs & derivatives
|
| 653 |
|
|
|a Colloids
|
| 653 |
|
|
|a Hyaluronic Acid
|
| 653 |
|
|
|a Biopolymers
|
| 653 |
|
|
|a Biomedical materials
|
| 653 |
|
|
|a Peptides / therapeutic use
|
| 653 |
|
|
|a Anemia / Treatment
|
| 653 |
|
|
|a Fructans / Analysis
|
| 653 |
|
|
|a Gene Therapy
|
| 653 |
|
|
|a Nanoparticles
|
| 653 |
|
|
|a Hyaluronic acid / Scientific applications
|
| 653 |
|
|
|a Microspheres (Pharmacy)
|
| 653 |
|
|
|a Microspheres
|
| 653 |
|
|
|a Starch in medicine / Derivatives
|
| 653 |
|
|
|a Fructans / Therapeutic use
|
| 653 |
|
|
|a Starch / therapeutic use
|
| 653 |
|
|
|a Cellulose / Derivatives / Application
|
| 653 |
|
|
|a Proteins / Therapeutic use
|
| 653 |
|
|
|a Gene therapy
|
| 653 |
|
|
|a Fructans / analysis
|
| 653 |
|
|
|a Hyaluronic acid / Evaluation
|
| 653 |
|
|
|a Drug Delivery Systems
|
| 653 |
|
|
|a Fructans / therapeutic use
|
| 653 |
|
|
|a Anemia / therapy
|
| 653 |
|
|
|a Biomedical and Dental Materials
|
| 653 |
|
|
|a Viscoelastic Substances
|
| 653 |
|
|
|a Carbohydrate drugs
|
| 653 |
|
|
|a Magnetic resonance imaging
|
| 653 |
|
|
|a Drug Compounding
|
| 653 |
|
|
|a Magnetic Resonance Imaging
|
| 653 |
|
|
|a Pharmaceutical Preparations
|
| 653 |
|
|
|a Clinical Laboratory Techniques
|
| 653 |
|
|
|a Oral medication / Formation
|
| 653 |
|
|
|a TECHNOLOGY & ENGINEERING / Chemical & Biochemical / bisacsh
|
| 653 |
|
|
|a Magnetic separation / Utilization
|
| 653 |
|
|
|a Drugs / Controlled release
|
| 653 |
|
|
|a Chitosan
|
| 653 |
|
|
|a Chitosan / Properties
|
| 700 |
1 |
|
|a Ravenelle, François
|e [editor]
|
| 700 |
1 |
|
|a Zhu, Xiao Xia
|e [editor]
|
| 710 |
2 |
|
|a American Chemical Society
|b Cellulose and Renewable Materials Division
|
| 710 |
2 |
|
|a American Chemical Society
|b Meeting ( 2004, Philadelphia, Pennsylvania)
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b ACS
|a ACS Symposium Series
|
| 490 |
0 |
|
|a ACS symposium series
|
| 500 |
|
|
|a Developed from a symposium sponsored by the ACS Division of Cellulose and Renewable Materials at the 228th ACS National Meeting, Philadelphia, Pennsylvania, August 22-26, 2004. - Distributed in print by Oxford University Press
|
| 856 |
4 |
0 |
|u https://pubs.acs.org/doi/book/10.1021/bk-2006-0934
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 615/.6
|